PNC-27Anti-CancerSafety Rating 5/10

Primary research areaAnticancer research

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose rangeResearch compound only. No established human dosing protocol. Animal studies variable.
AdministrationVaries
Safety5/10 · Not FDA-approved
NCAA D1Not listed

Price Comparison

Compare vendors

4 vendors competing

VendorPrice$ / mgUpdated
Core PeptidesBest $/mgCOA ✓ · 3P$138.00$27.60Apr 16, 2026Buy →
BioLongevity LabsCOA ✓ · 3P$279.97$28.00Apr 16, 2026Buy →
PureRawzCOA ✓ · 3P$163.40$32.68May 14, 2026Buy →
Behemoth LabzCOA ✓ · 3P$170.38$34.08May 14, 2026Buy →

Overview

About PNC-27

Mechanism of action

Synthetic peptide containing p53 activation domain fused to penetratin cell-penetrating sequence; selectively inserts into membranes of cancer cells (which overexpress HDM2); induces apoptosis in cancer cells while leaving normal cells unharmed.

Safety profile

Limited human data. Animal studies show selective cancer cell killing with minimal normal cell toxicity. Long-term safety profile not established. · Experimental; designed for cancer cell selectivity; limited data; no proven harms

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on PNC-27

Failed to fetch